All News #Library
Biotech
Neurotech Secures Permanent J-Code For Encelto™ From October 1
29 Sep 2025 //
BUSINESSWIRE
Neurotech Appoints Peter J. McDonnell to the Board of Directors
02 Sep 2025 //
BUSINESSWIRE
First FDA-Approved MacTel Treatment Performed
11 Aug 2025 //
BUSINESSWIRE
Neurotech’s Encelto Approved by the FDA for Macular Telangiectasia
06 Mar 2025 //
BUSINESSWIRE
Neurotech Updates BLA for NT-501 in MacTel Treatment
08 Nov 2024 //
BUSINESSWIRE
Neurotech`s NT-501 For MacTel Treatment Receives Priority BLA Review
20 Jun 2024 //
BUSINESSWIRE

Market Place
Sourcing Support